Healthcare Roundup – Nextleaf nabs second license, Tivity Health inks deal with Walmart

医疗保健 Nextleaf获得第二份许可证,Tivity Health与沃尔玛达成交易
Published on: January 23, 2020
Author: Amy Liu

Nextleaf nabs second license in Canada

  • Under the Cannabis Act, Health Canada has awarded a Research License to Nextleaf Solutions (OTCPK:OILFF) permitting it to conduct certain R&D activities, including stability studies on its nanoemulsified water-soluble THC and CBD formulations. It may also conduct human administration trials for sensory evaluation.
  • It received a Standard Processing License in September 2019.

Tivity Health inks deal with Walmart

  • Tivity Health (TVTY +0.1%) is now offering its Prime Fitness program to Walmart’s (WMT -0.2%) 1.5M associates and their dependents in the U.S. Members will have access to more than 9,000 fitness locations for a little as $9 per paycheck.
  • Tivity says it now offers Prime Fitness to 43M people between the ages of 18-64. Health clubs 24 Hour Fitness and Planet Fitness are national partners.

Sanofi finalizes Synthorx buy

  • Sanofi (SNY +0.2%) has completed its $2.5B acquisition of Synthorx (NASDAQ:THOR) announced last month.

Moderna nabs funding to make vaccine against China coronavirus

  • The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition aimed at accelerating the development of vaccines, has agreed to fund the manufacture of Moderna’s (MRNA -1.8%) mRNA vaccine against the coronavirus causing the outbreak in China, named 2019-nCoV.
  • NIH’s National Institute of Allergy and Infectious Diseases (NIAID), Moderna’s collaborator on the design of the vaccine, will conduct IND-enabling studies as well as a Phase 1 clinical trial.

Pfizer to offer generic Viagra through digital health clinic

  • Pfizer (NYSE:PFE) subsidiary Greenstone inks a supply agreement with Roman, a digital healthcare clinic for men, to offer its authorized generic version of Viagra (sildenafil citrate) to Roman members.
  • The product will be manufactured in Europe in the same facilities that make branded Viagra.

Biotechnology COVID-19 Healthcare Services Life Science